Work

Abstract OT2-01-03: Phase II Trial of the addition of pembrolizumab to letrozole and palbociclib in patients with metastatic estrogen receptor positive breast cancer who have stable disease on letrozole and palbociclib

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-ot2-01-03

Authors: Y Yuan, P Frankel, T Synold, S Yost, P Lee, J Waisman, G Somlo, A Hurria, J Mortimer

Institutions: City Of Hope National Medical Center, City of Hope

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594138643

Cites:

Cited by: 2

Related to: 10